<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: New Analyses from Pivotal Phase 3 Trials of Oral Ozanimod to Be Presented at ECTRIMS 2018	</title>
	<atom:link href="https://www.novumpr.nl/2018/10/10/new-analyses-from-pivotal-phase-3-trials-of-oral-ozanimod-to-be-presented-at-ectrims-2018/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.novumpr.nl/2018/10/10/new-analyses-from-pivotal-phase-3-trials-of-oral-ozanimod-to-be-presented-at-ectrims-2018/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=new-analyses-from-pivotal-phase-3-trials-of-oral-ozanimod-to-be-presented-at-ectrims-2018</link>
	<description>NovumPR press releases</description>
	<lastBuildDate>Wed, 10 Oct 2018 12:56:10 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.2</generator>
</channel>
</rss>
